TNFα genotype affects TNFα release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis

Journal of Hepatology

Volumn 43, Issue 6, 2005, Pages 944-950

  Valenti, Luca ^a   Pulixi, Edoardo ^a   Fracanzani, Anna Ludovica ^a   Dongiovanni, Paola ^a   Maggioni, Marco ^b   Orsatti, Alessandra ^a   Gianni, Cristina ^c   Fargion, Silvia ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Diabetes; Fatty liver; HCV; Hepatitis; Inflammation; Insulin resistance; Steatosis; TNF promoter polymorphism

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; INSULIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; GENE ACTIVITY; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; BIOSYNTHESIS; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; AGED; DIABETES MELLITUS; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27744512909     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.05.035     Document Type: Article

References (43)

1. S. Caronia, K. Taylor, L. Pagliaro, C. Carr, U. Palazzo, and J. Petrik Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection Hepatology 30 1999 1059 1063
2. J.M. Petit, J.B. Bour, C. Galland-Jos, A. Minello, B. Verges, and M. Guiguet Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C J Hepatol 35 2001 279 283
3. M. Sougleri, C. Labropoulou-Karatza, P. Paraskevopoulou, H. Fragopanagou, and T. Alexandrides Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with alpha-thalassaemia major Eur J Gastroenterol Hepatol 13 2001 1195 1199
4. H.B. El-Serag, P.A. Richardson, and J.E. Everhart The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans Am J Gastroenterol 96 2001 2462 2467
5. M.M. Hassan, L.Y. Hwang, C.J. Hatten, M. Swaim, D. Li, and J.L. Abbruzzese Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus Hepatology 36 2002 1206 1213
6. S.H. Mehta, F.L. Brancati, S.A. Strathdee, J.S. Pankow, D. Netski, and J. Coresh Hepatitis C virus infection and incident type 2 diabetes Hepatology 38 2003 50 56
7. L.E. Adinolfi, M. Gambardella, A. Andreana, M.F. Tripodi, R. Utili, and G. Ruggiero Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358 1364
8. N. Akuta, F. Suzuki, A. Tsubota, Y. Suzuki, T. Someya, and M. Kobayashi Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors J Hepatol 37 2002 831 836
9. L. Rubbia-Brandt, R. Quadri, K. Abid, E. Giostra, P.J. Male, and G. Mentha Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 J Hepatol 33 2000 106 115
10. J. Westin, H. Nordlinder, M. Lagging, G. Norkrans, and R. Wejstal Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients J Hepatol 37 2002 837 842
11. A.J. Czaja, H.A. Carpenter, P.J. Santrach, and S.B. Moore Host- and disease-specific factors affecting steatosis in chronic hepatitis C J Hepatol 29 1998 198 206
12. A. Monto, J. Alonzo, J.J. Watson, C. Grunfeld, and T.L. Wright Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol Hepatology 36 2002 729 736
13. D. Kumar, G.C. Farrell, C. Fung, and J. George Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response Hepatology 36 2002 1266 1272
14. V. Paradis, G. Perlemuter, F. Bonvoust, D. Dargere, B. Parfait, and M. Vidaud High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis Hepatology 34 2001 738 744
15. L.F. Hourigan, G.A. Macdonald, D. Purdie, V.H. Whitehall, C. Shorthouse, and A. Clouston Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis Hepatology 29 1999 1215 1219
16. P.A. Gochee, J.R. Jonsson, A.D. Clouston, N. Pandeya, D.M. Purdie, and E.E. Powell Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-alpha and cytochrome P450 2E1 J Gastroenterol Hepatol 18 2003 386 392
17. H. Knobler, T. Zhornicky, A. Sandler, N. Haran, Y. Ashur, and A. Schattner Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association Am J Gastroenterol 98 2003 2751 2756
18. S. Aytug, D. Reich, L.E. Sapiro, D. Bernstein, and N. Begum Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes Hepatology 38 2003 1384 1392
19. G.S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M.F. White, and B.M. Spiegelman IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance Science 271 1996 665 668
20. Y. Shintani, H. Fujie, H. Miyoshi, T. Tsutsumi, K. Tsukamoto, and S. Kimura Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance Gastroenterology 126 2004 840 848
21. H. Knobler, and A. Schattner TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad Q J Med 98 2005 1 6
22. A.H. Hajeer, and I.V. Hutchinson Influence of TNFalpha gene polymorphisms on TNFalpha production and disease Hum Immunol 62 2001 1191 1199
23. T. Ishii, H. Hirose, I. Saito, K. Nishikai, H. Maruyama, and T. Saruta Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men Metabolism 49 2000 1616 1618
24. B.T. Heijmans, R.G. Westendorp, S. Droog, C. Kluft, D.L. Knook, and P.E. Slagboom Association of the tumour necrosis factor alpha -308G/A polymorphism with the risk of diabetes in an elderly population-based cohort Genes Immun 3 2002 225 228
25. L. Valenti, A.L. Fracanzani, P. Dongiovanni, G. Santorelli, A. Branchi, and E. Taioli Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 2002 274 280
26. D. Lio, C. Caruso, R. Di Stefano, G. Colonna Romano, D. Ferraro, and L. Scola IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection Hum Immunol 64 2003 674 680
27. H.R. Rosen, J.J. Lentz, S.L. Rose, J. Rabkin, C.L. Corless, and K. Taylor Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation Transplantation 68 1999 1898 1902
28. K. Tokushige, N. Tsuchiya, K. Hasegawa, E. Hashimoto, K. Yamauchi, and T. Komatsu Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV Am J Gastroenterol 98 2003 160 166
29. L.J. Yee, J. Tang, J. Herrera, R.A. Kaslow, and D.J. van Leeuwen Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection Genes Immun 1 2000 386 390
30. A. Costa, J.M. Fernandez-Real, J. Vendrell, M. Broch, R. Casamitjana, and W. Ricart Lower rate of tumor necrosis factor-alpha -863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes Metabolism 52 2003 1068 1071
31. G.S. Hotamisligil, P. Arner, R.L. Atkinson, and B.M. Spiegelman Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance Diabetes 46 1997 451 455
32. H. Zylberberg, A.C. Rimaniol, S. Pol, A. Masson, D. De Groote, and P. Berthelot Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity J Hepatol 30 1999 185 191
33. C.L. Thio, J.J. Goedert, T. Mosbruger, D. Vlahov, S.A. Strathdee, and S.J. O'Brien An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection Genes Immun 5 2004 294 300
34. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
35. S.M. Haffner, H. Miettinen, and M.P. Stern The homeostasis model in the San Antonio Heart study Diabetes Care 20 1997 1087 1092
36. E. Bonora, G. Targher, M. Alberiche, R.C. Bonadonna, F. Saggiani, and M.B. Zenere Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity Diabetes Care 23 2000 57 63
37. T. Skoog, F.M. van't Hooft, B. Kallin, S. Jovinge, S. Boquist, and J. Nilsson A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha Hum Mol Genet 8 1999 1443 1449
38. G.S. Hotamisligil Inflammatory pathways and insulin action Int J Obes Relat Metab Disord 27 2003 S53 S55
39. J. Crespo, M. Rivero, E. Fabrega, A. Cayon, J.A. Amado, and M.T. Garcia-Unzeta Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis Dig Dis Sci 47 2002 1604 1610
40. M. Varela-Rey, C. Montiel-Duarte, J.A. Oses-Prieto, M.J. Lopez-Zabalza, J.P. Jaffrezou, M. Rojkind 43 p38 MAPK mediates the regulation of alpha1 (I) procollagen mRNA levels by TNF-alpha and TGF-beta in a cell line of rat hepatic stellate cells (1) Fed Eur Biochem Soc Lett 528 2002 133 138
41. E.E. Powell, C.J. Edwards-Smith, J.L. Hay, A.D. Clouston, D.H. Crawford, C. Shorthouse 44 Host genetic factors influence disease progression in chronic hepatitis C Hepatology 31 2000 828 833
42. M.J. Bahr, M. el Menuawy, K.H. Boeker, P.B. Musholt, M.P. Manns, and R. Lichtinghagen Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C Liver Int 23 2003 420 425
43. D. Cai, M. Yuan, D.F. Frantz, P.A. Melendez, L. Hansen, and J. Lee Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat Med 11 2005 183 190